These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 14567088)

  • 21. Comprehensive analysis of prognostic factors in hospitalized patients with pneumonia occurring outside hospital: Serum albumin is not less important than pneumonia severity assessment scale.
    Miyazaki H; Nagata N; Akagi T; Takeda S; Harada T; Ushijima S; Aoyama T; Yoshida Y; Yatsugi H; Fujita M; Watanabe K
    J Infect Chemother; 2018 Aug; 24(8):602-609. PubMed ID: 29628384
    [TBL] [Abstract][Full Text] [Related]  

  • 22. De-escalation therapy in ventilator-associated pneumonia.
    Rello J; Vidaur L; Sandiumenge A; Rodríguez A; Gualis B; Boque C; Diaz E
    Crit Care Med; 2004 Nov; 32(11):2183-90. PubMed ID: 15640629
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Guidelines for treatment of pneumonia in intensive care units].
    Emmi V
    Infez Med; 2005; Suppl():7-17. PubMed ID: 16801748
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The attributable cost and length of hospital stay because of nosocomial pneumonia in intensive care units in 3 hospitals in Argentina: a prospective, matched analysis.
    Rosenthal VD; Guzman S; Migone O; Safdar N
    Am J Infect Control; 2005 Apr; 33(3):157-61. PubMed ID: 15798670
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Trends in the treatment of pneumonia].
    Grassi V; Romanelli G
    Recenti Prog Med; 1999; 90(7-8):373-9. PubMed ID: 10429515
    [No Abstract]   [Full Text] [Related]  

  • 26. Prospective, randomised study to compare empirical treatment versus targeted treatment on the basis of the urine antigen results in hospitalised patients with community-acquired pneumonia.
    Falguera M; Ruiz-González A; Schoenenberger JA; Touzón C; Gázquez I; Galindo C; Porcel JM
    Thorax; 2010 Feb; 65(2):101-6. PubMed ID: 19703825
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Community-acquired pneumonia--treatment perspectives in the physician's office].
    Ewig S
    MMW Fortschr Med; 2004 May; 146(21):43-5. PubMed ID: 15373084
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Ambulatory management of community-acquired pneumonia in the adult. II: Therapeutic strategy and follow-up].
    Lamy O
    Praxis (Bern 1994); 2002 Nov; 91(45):1915-20. PubMed ID: 12462894
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Healthcare-associated pneumonia: diagnostic criteria and distinction from community-acquired pneumonia.
    Falcone M; Venditti M; Shindo Y; Kollef MH
    Int J Infect Dis; 2011 Aug; 15(8):e545-50. PubMed ID: 21616695
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Roles of the Charlson Comorbidity Index and Time to First Antibiotic Dose as Predictors of Outcome in Pneumococcal Community-Acquired Pneumonia.
    Franzen D; Lim M; Bratton DJ; Kuster SP; Kohler M
    Lung; 2016 Oct; 194(5):769-75. PubMed ID: 27405854
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Community acquired pneumococcal pneumonia in hospitalized adult patients].
    Díaz A; Torres C; Flores LJ; García P; Saldías F
    Rev Med Chil; 2003 May; 131(5):505-14. PubMed ID: 12879811
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ventilator-associated pneumonia: a review.
    Joseph NM; Sistla S; Dutta TK; Badhe AS; Parija SC
    Eur J Intern Med; 2010 Oct; 21(5):360-8. PubMed ID: 20816584
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Community-acquired pneumonia].
    Blanquer J; Sanz F
    Arch Bronconeumol; 2010 Oct; 46 Suppl 7():26-30. PubMed ID: 21316547
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The hospitalist perspective on treatment of community-acquired bacterial pneumonia.
    Amin AN; Cerceo EA; Deitelzweig SB; Pile JC; Rosenberg DJ; Sherman BM
    Postgrad Med; 2014 Mar; 126(2):18-29. PubMed ID: 24685965
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Guidelines for the epidemiology, diagnosis, antimicrobial therapy and management of community-acquired pneumonia and lower respiratory tract infections in adults].
    Höffken G; Lorenz J; Kern W; Welte T; Bauer T; Dalhoff K; Dietrich E; Ewig S; Gastmeier P; Grabein B; Halle E; Kolditz M; Marre R; Sitter H
    Dtsch Med Wochenschr; 2010 Feb; 135(8):359-65. PubMed ID: 20166002
    [No Abstract]   [Full Text] [Related]  

  • 36. Effects of delayed oxygenation assessment on time to antibiotic delivery and mortality in patients with severe community-acquired pneumonia.
    Blot SI; Rodriguez A; Solé-Violán J; Blanquer J; Almirall J; Rello J;
    Crit Care Med; 2007 Nov; 35(11):2509-14. PubMed ID: 17901833
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nosocomial pneumonia in the ICU--year 2000 and beyond.
    Bowton DL
    Chest; 1999 Mar; 115(3 Suppl):28S-33S. PubMed ID: 10084457
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Narrow-spectrum ß-lactam monotherapy in hospital treatment of community-acquired pneumonia: a register-based cohort study.
    Rhedin S; Galanis I; Granath F; Ternhag A; Hedlund J; Spindler C; Naucler P
    Clin Microbiol Infect; 2017 Apr; 23(4):247-252. PubMed ID: 28017793
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Actualities of adults' ventilator-associated pneumonia].
    Svediene S; Ivaskevicius J
    Medicina (Kaunas); 2006; 42(2):91-7. PubMed ID: 16528124
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Management of adult patients with community-acquired pneumonia. Evidence-based guidelines from the Swedish Infectious Diseases Association].
    Strålin K; Goscinski G; Hedlund J; Lidman C; Spindler C; Ortqvist A; Holmberg H
    Lakartidningen; 2008 Sep 17-23; 105(38):2582-7. PubMed ID: 18846863
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.